We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DTE:XETRDeutsche Telekom AG Analysis

Data as of 2026-03-09 - not real-time

$148.96

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Technical outlook: The 20‑day SMA sits comfortably above both the 50‑day and 200‑day SMAs, confirming a bullish trend. The RSI is in the high‑60s, indicating strength without being overbought, while the MACD histogram remains positive, reinforcing momentum. Price is trading near the upper half of its 52‑week range, with a clear support zone around $134 and resistance near $155, and volume has remained stable, suggesting disciplined buying. A low beta further points to limited volatility relative to the broader market.
Fundamental backdrop: DTE delivered a revenue surge of nearly 30% YoY and posted operating margins above 15%, underpinning solid profitability. The latest earnings beat expectations, and the company announced a 3% dividend with a 63% payout ratio, highlighting attractive cash returns. Despite a high debt load, the regulated utility model provides predictable cash flows, and a DCF‑derived fair value of roughly $311 signals the stock is undervalued at current levels. Combined with a strong dividend and growth trajectory, the fundamentals support a positive outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish SMA crossover and positive MACD
  • Recent earnings beat and dividend declaration
  • Support level providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value far above market price
  • Sustained revenue growth and solid operating margins
  • Attractive dividend yield with reasonable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Regulated utility model offering stable cash flows
  • Expansion into renewables and energy services
  • Long‑term dividend sustainability and value upside

Key Metrics & Analysis

Financial Health

Revenue Growth28.90%
Profit Margin9.25%
P/E Ratio21.2
ROE12.18%
ROA2.94%
Debt/Equity213.60
P/B Ratio2.5
Op. Cash Flow$3.4B
Free Cash Flow$-1746625024
Industry P/E20.8

Technical Analysis

TrendBullish
RSI67.5
Support$134.03
Resistance$154.63
MA 20$145.11
MA 50$137.74
MA 200$136.61
MACDBullish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair Value$310.98
Target Price$151.50
Upside/Downside1.71%
GradeUndervalued
TypeBlend
Dividend Yield3.00%

Risk Assessment

Beta0.23
Volatility16.90%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.